Kermit Richiez Colon, MD
Gastroenterology · Hato Rey, PRNPI 1003933417
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 80.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $6,718 and has fallen 84.3% since, to $1,055 in 2025. Among gastroenterology clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $102.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Madrigal Pharmaceuticals$556
- Johnson & Johnson$411
- E.r. Squibb & Sons, L.L.C.$322
- Olympus Latin America, Inc.$272
- Intercept Pharmaceuticals, Inc.$150
- plus $487 from 7 others
Across 21 payments — averaging $667.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$14K
What the payments were for
- Speaking & faculty fees$5,62551%
- Travel & lodging$1,16711%
- Food & beverage$4,29739%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $8,892 |
| Madrigal Pharmaceuticals | 6 | $556 |
| Johnson & Johnson(2 entities) | 13 | $411 |
| E.r. Squibb & Sons, L.L.C. | 10 | $322 |
| Olympus Latin America, Inc. | 2 | $272 |
| Intercept Pharmaceuticals, Inc. | 2 | $150 |
| PBG Puerto Rico LLC | 5 | $107 |
| Boston Scientific | 1 | $99 |
| Merck | 1 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $66 |
| Exact Sciences | 2 | $50 |
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $47 |
| Sanofi | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Humira$7,002
- REZDIFFRA$290
- Skyrizi$250
- Rinvoq$249
- RESMETIROM$225
- Mavyret$216
- EVIS EXERA II ULTRASOUND GASTROVIDEOSCOPE$147
- OCALIVA$125
- ZEPOSIA$125
- EVIS EXERA III COLONOVIDEOSCOPE$125
- Tremfya$117
- STELARA$117
How this compares
$11,090 in reported general payments places this provider in the 90th percentile of 198 gastroenterology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 14 | $95,366 |
| RinvoqUpadacitinib | 13 | $83,606 |
| SuprepSodium, Potassium,mag Sulfates | 295 | $34,810 |
| LinzessLinaclotide | 27 | $19,908 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 114 | $8,874 |
| Mesalamine | 38 | $6,566 |
| Mesalamine DrMesalamine | 18 | $5,672 |
| Naloxone Hcl | 513 | $5,402 |
| Pantoprazole Sodium | 442 | $3,701 |
| Sucralfate | 16 | $2,138 |
| Ursodiol | 22 | $1,807 |
| Omeprazole | 163 | $1,312 |
| Flumazenil | 146 | $1,276 |
| Esomeprazole Magnesium | 49 | $1,057 |
| Meperidine HclMeperidine Hcl/Pf | 190 | $981 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Linzess | $8,892 | $103,51440 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 198 gastroenterology providers in Puerto Rico.
Other gastroenterology in Hato Rey
- Rafael Pastrana LabordeHato Rey$76K
- Ahmed Morales JorgeCoto Laurel$214K
- Barbara Rosado CarrionPonce$176K
- Miguel de Varona-NegronCaguas$68K
- Marcia Cruz CorreaSan Juan$62K
- Francisco CebolleroMayaguez$52K
- Loscar SantiagoSan Juan$39K
- Henry Gonzalez RiveraSan Juan$34K
- Hector LozanoSan Juan$28K
- Carlos MicamesMayaguez$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.